United States· US:87441-050_5519bc30-e179-d374-e063-6294a90a7fe9

Lorazepam

A lorazepam product containing lorazepam, registered in United States by Unit Dose Solutions, Inc.. The same ATC class is registered in 16 of our 19 countries.

ATC N05BA06

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLorazepamATCN05BA06REGISTER NO.US:87441-050_5519bc30…PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Lorazepam is registered in 16 of 19 countries.

Countries holding a registration under ATC N05BA06 (lorazepam), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose

Lorazepam · ATC N05BA06

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lorazepam costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.084 in France to $0.81 in Switzerland — a ×9.6 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Lorazepam · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.81
  • ES Spain$0.16
  • FR France$0.084
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
LORAZEPAM
Manufacturer
Unit Dose Solutions, Inc.
Country
United States (US)
ATC code
N05BA06
ATC class
Lorazepam
Defined daily dose
2.5 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    87441-050-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

413 interactions on record for lorazepam.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lorazepam · interactions on record

413 records

  • 4 severe
  • 70 moderate
  • 22 minor
  • 266 info

Most severe, free to view

  • MorphineN02AA01severe
  • MorphinN07BC09severe
  • HydrocodoneR05DA03severe
  • CodeineR05DA04severe

51 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lorazepam in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lorazepam products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Lorazepam Macure, Temesta
  • Belgium · Lambutrix, Lorazepam Ab
  • Bulgaria · Лоразепам Tzf, Лорапам
  • Cyprus · Lorans, Lorivan
  • Czechia · Temelor
  • Germany · Lorazepam Aristo, Lorazepam Dura
  • Denmark · Lorazepam Macure, Lorazepam Orion
  • Estonia · Lorans, Temelor
  • Spain · Lorazepam Aurovitas, Lorazepam Cinfa
  • Finland · Lorazepam Macure, Lorazepam Orion
  • France · Lorazepam Arrow, Lorazepam Viatris
  • United Kingdom (Northern Ireland) · Lorazepam, Lorazepam Alissa Healthcare Research
  • Greece · Akivass, Dorm
  • Croatia · Lorsilan, Temelor
  • Hungary · Loranxil, Lorazepam Orion
  • Ireland · Ativan, Lorazepam Aspire Pharma (Malta)
  • Italy · Control, Lorans
  • Lithuania · Dalixen, Lirezid
  • Luxembourg · Lambutrix, Lorazepam Eg
  • Latvia · Lorafen, Lorazepam Macure
  • Malta · Ativan, Lorivan
  • Netherlands · Lambutrix, Lorazepam Accord Healthcare
  • Norway · Lorazepam Macure, Rativor
  • Poland · Lorabex, Lorafen
  • Portugal · Ansilor, Lorazepam Aristo
  • Romania · Anxiar, Temelor
  • Sweden · Lorazepam Macure, Lorazepam Orion
  • Slovenia · Lorazepam Macure, Lorsilan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2ea3f20-80c6-432b-ad83-8e85f36a1705
GET /v1/drugs/f2ea3f20-80c6-432b-ad83-8e85f36a1705?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": ".5",
  "substance": "LORAZEPAM",
  "productndc": "87441-050",
  "dosage_form": "TABLET",
  "dea_schedule": "CIV",
  "strength_unit": "mg/1",
  "application_number": "ANDA072926",
  "marketing_category": "ANDA"
}

See everything about lorazepam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.